Abstract
Severe bleeding and haemorrhagic shock are frequent and challenging conditions in anaesthesiologic and intensive-care clinical practice. Major haemorrhage may occur in trauma patients, during and after surgery, and in other variety of critical pathologies, such as oesophageal bleeding in cirrhotic patients and intracranial haemorrhage. Uncontrolled haemorrhage is the most common cause of death in trauma patients and accounts for at least 60% of deaths in patients after hospital admission [1]. Mortality after an episode of intracerebral haemorrhage is very high (20–40%), and 80% of the survivors suffer severe neurological impairment [2]. Perioperative bleeding depends on the extent and complexity of surgical procedures and on the coagulation status of the patient. However, unexpected and massive bleeding may complicate any surgical procedure, leading to a significant increase in perioperative mortality from < 1% up to 20% [3]. Despite the significant improvement in surgical technique, major surgery for liver diseases, such as partial hepatectomy and orthotopic liver transplantation (OLT), is still associated with significant blood losses due to both technical factors and poor haemostasis of cirrhotic patients. The degree of blood losses during OLT has important effects on postoperative infection, graft survival, intensive-care stay, and mortality [4]. Excessive bleeding is a crucial problem also in cardiac surgery: massive blood loss is associated with an eight-fold increase in the odds of death [5], and up to 5% of patients need a second operation to control severe post-operative bleeding [6].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Lynn M, Jeroukhimov I, Klein Y, Martinowitz U (2002) Updates in the management of severe coagulopathy in trauma patients. Intensive Care Med 28(Suppl 2):241–247
Qureshi AI, Thurim S, Broderick JP et al (2001) Spontaneous intracerebral hemorrhage. N Engl J Med 344:1450–1460
Lawson JH, Murphy MP (2004) Challenges for providing effective hemostasis insurgery and trauma. Semin Hematol 41(Suppl 1):55–64
Mor E, Jennings L, Gonwa TA et al (1993) The impact of operative bleeding on outcome in transplantation of the liver. Surg Gynecol Obstet 176:219–227
Karkouti K, Wijeysundera DN, Yau TM et al (2004) The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 44:1453–1462
Rady MY, Ryan T, Starr NJ (1998) Perioperative determinants of morbidity and mortality in elderly patients undergoing cardiac surgery. Crit Care Med 26:225–235
Miller E, Paull DE, Morrissey K et al (1988) Scalpel versus electrocautery in modified radical mastectomy. Am Surg 54:284–286
National Prospective Tonsillectomy Audit (2004) Tonsillectomy technique as a risk factor for postoperative haemorrhage. Lancet 364:697–702
Eddy VA, Morris JA, Cullinane DC (2000) Hypothermia, coagulopathy, acidosis. Surg Clin North Am 80:845–854
Koh MB, Hunt BJ (2003) The management of perioperative bleeding. Blood Rev 17:179–185
Henry DA, Moxey AJ, Carless PA et al (2001) Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 1:CD001886
Casati V, Sandrelli L, Speziali G et al (2002) Hemostatic effects of tranexamic acid in elective thoracic aortic surgery: a prospective, randomized, double-blind, placebo-controlled study. J Thorac Cardiovasc Surg 123:1084–1091
Carless PA, Henry DA, Moxey AJ et al (2004) Desmopressin for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 1:CD001884
Levi M, Cromheecke ME, de Jonge E et al (1999) Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints. Lancet 354:1940–1947
Grounds M (2003) Recombinant factor VIIa and its use in severe bleeding in surgery and trauma: a review. Blood Rev 17:S11–S21
Ghorashian S, Beverly JH (2004) Off license use of recombinant activated factor VII. Blood Rev 18:245–259
Levi M, Peters M, Büller HR (2005) Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit Care Med 33:883–890
O’Connell NM, Perry DJ, Hodgson AJ et al (2003) Recombinant FVIIa in the management of uncontrolled hemorrhage. Transfusion 43:1649–1651
Eikelboom JW, Bird R, Blythe D et al (2003) Recombinant activated factor VII for the treatment of life-threatening haemorrhage. Blood Coagul Fibrinolysis 14:713–717
Clark AD, Gordon WC, Walker ID, Tait RC (2004) ‘Last-ditch’ use of recombinant factor VIIa in patients with massive haemorrhage is ineffective. Vox Sang 86:120–124
Brott T, Broderick J, Kothari R et al (1997) Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 28:1–5
Mayer SA (2003) Ultra-early hemostatic therapy for intracerebral hemorrhage. Stroke 32:224–229
Mayer SA, Brun NC, Begtrup K et al (2005) Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 352:777–785
Kenet G, Walden R, Eldad A et al (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 354:1879
Tobias JD, Berkenbosch JW, Muruve NA et al (2002) Correction of a coagulopathy using recombinant factor VII before removal of an intra-aortic balloon pump. J Cardiothorac Vasc Anesth 16:612–614
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag Italia
About this paper
Cite this paper
Girardis, M., Busani, S., Marietta, M. (2006). Severe bleeding in critical care. In: Gullo, A. (eds) Anaesthesia, Pain, Intensive Care and Emergency A.P.I.C.E.. Springer, Milano. https://doi.org/10.1007/88-470-0407-1_62
Download citation
DOI: https://doi.org/10.1007/88-470-0407-1_62
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0406-1
Online ISBN: 978-88-470-0407-8
eBook Packages: MedicineMedicine (R0)